Optimization of human myoblasts culture under different media conditions for application in the

CD markers Myoblasts cell therapy growth media in vitro culture muscle progenitor

Journal

American journal of stem cells
ISSN: 2160-4150
Titre abrégé: Am J Stem Cells
Pays: United States
ID NLM: 101578936

Informations de publication

Date de publication:
2022
Historique:
received: 30 09 2021
accepted: 30 12 2021
entrez: 17 3 2022
pubmed: 18 3 2022
medline: 18 3 2022
Statut: epublish

Résumé

Human primary

Identifiants

pubmed: 35295592
pmc: PMC8918417

Types de publication

Journal Article

Langues

eng

Pagination

1-11

Informations de copyright

AJSC Copyright © 2022.

Déclaration de conflit d'intérêts

MS is CMO and shareholder of Dystrogen Therapeutics SA, KS, MS, KK, KB, AC are Dystrogen Therapeutics SA employee; NR is scientific consultant of Dystrogen Therapeutics SA.

Références

BMC Musculoskelet Disord. 2006 Mar 07;7:23
pubmed: 16522209
Semin Cell Dev Biol. 2020 Aug;104:93-104
pubmed: 32005567
Stem Cell Res Ther. 2017 Jul 4;8(1):158
pubmed: 28676130
BJU Int. 2010 Jun;105(11):1598-603
pubmed: 19912190
Stem Cell Rev Rep. 2021 Jun;17(3):878-899
pubmed: 33349909
Skelet Muscle. 2017 Nov 16;7(1):26
pubmed: 29145886
Nat Protoc. 2008;3(9):1501-9
pubmed: 18772878
Tech Coloproctol. 2015 Nov;19(11):685-96
pubmed: 26266767
Front Physiol. 2019 Aug 21;10:1074
pubmed: 31496956
Eur Heart J. 2005 Jun;26(12):1188-95
pubmed: 15764613
Hum Gene Ther. 2001 Apr 10;12(6):619-28
pubmed: 11426462
Int J Mol Sci. 2021 Oct 08;22(19):
pubmed: 34639225
PLoS One. 2013 Sep 03;8(9):e73231
pubmed: 24019912
Sci Rep. 2021 Oct 6;11(1):19825
pubmed: 34615887
J Cell Biol. 1998 Sep 7;142(5):1257-67
pubmed: 9732286
Dev Biol. 2000 May 1;221(1):112-9
pubmed: 10772795
Arch Immunol Ther Exp (Warsz). 2018 Oct;66(5):341-354
pubmed: 29536116
Antioxidants (Basel). 2020 Sep 02;9(9):
pubmed: 32887483
Int J Mol Med. 2014 Jul;34(1):83-91
pubmed: 24788458
Cell Stem Cell. 2008 Sep 11;3(3):301-13
pubmed: 18786417
Biogerontology. 2011 Aug;12(4):349-65
pubmed: 21512720
Eur J Heart Fail. 2017 Jan;19(1):148-157
pubmed: 28052545
PLoS One. 2018 Mar 22;13(3):e0194561
pubmed: 29566057
Sci Rep. 2020 Jan 14;10(1):229
pubmed: 31937892
Methods Mol Biol. 2013;976:53-65
pubmed: 23400434

Auteurs

Natalia Rozwadowska (N)

Dystrogen Therapeutics SA Poznan 60-316, Poland.
Institute of Human Genetics, Polish Academy of Sciences Poznan 60-479, Poland.

Maria Sikorska (M)

Dystrogen Therapeutics SA Poznan 60-316, Poland.

Katarzyna Bozyk (K)

Dystrogen Therapeutics SA Poznan 60-316, Poland.

Klaudia Jarosinska (K)

Dystrogen Therapeutics SA Poznan 60-316, Poland.

Anna Cieciuch (A)

Dystrogen Therapeutics SA Poznan 60-316, Poland.

Sonia Brodowska (S)

Dystrogen Therapeutics SA Poznan 60-316, Poland.

Marcin Andrzejczak (M)

Medical Center HCP Poznan 61-485, Poland.

Maria Siemionow (M)

Dystrogen Therapeutics SA Poznan 60-316, Poland.
Department of Orthopaedics, University of Illinois at Chicago Chicago, Illinois, IL 60607, USA.

Classifications MeSH